Diclofenac Patches Market 2021 Global Industry Size, Share, Trends, Growth Factors, Key Countries Analysis By Leading Players With Forecast to 2026

SEATTLE, April 01, 2021, (PHARMIWEB) — Global Diclofenac Patches Market

Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID), which helps in reducing the effect of hormones that cause inflammation and pain in the body. NSAIDs are the most widely used therapeutic class of analgesic compounds, indicated for use in relieving post-extraction pain. Diclofenac sodium is a commonly prescribed NSAID, which exhibits anti-inflammatory, analgesic and anti-pyretic properties. Transdermal diclofenac patches are used to provide temporary relief from minor aches and pains of the muscle and joints. These patches are found to be more effective as compared to diclofenac tablets, owing to their once-daily application and lesser frequency of systemic adverse effects. Transdermal patches have been developed to offer an innovative drug delivery system for diclofenac, with reduced incidence of systemic adverse effects, due to lower plasma concentrations. Diclofenac patches are designed to treat pain associated with conditions, such as gout, migraine, rheumatoid arthritis, sprains of muscles and joints, and mild-to-moderate fever in some cases.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/1792

Global Diclofenac Patches Market Drivers

The global diclofenac patches market is expected to experience considerable growth over the forecast period, owing to the high prevalence of chronic pain conditions. As estimated by the National Institutes of Health (NIH), one of every 10 people in the U.S. suffers from chronic pain. According to a study published in the British Medical Journal in 2016, nearly one-third to half of the population in the U.K. suffers from chronic pain. Moreover, rising prevalence of pain and increasing prevalence of diseases, such as cancer, are supplementing the global market growth. As reported by the National Cancer Institute in 2018, around 1,735,350 new cases of cancer are expected to be diagnosed in the U.S. in the near future. Additionally, India, China and other Eastern and Central Asian countries accounted for nearly half of the new cancer cases and deaths reported worldwide in 2017.

Growing research developments in the NSAIDs to increase its effectiveness pain management and to extend its application in various areas of medical field, will drive the diclofenac patches market. For instance, a study published in the International Journal of Ophthalmology: April 2018, stated that, application of prophylactic non-steroidal anti-inflammatory drugs (NSAIDs) in pre- and post-cataract surgery may help to reduce the severity and frequency of the development of cystoid macular edema (CME) in the eyes of diabetic patients. Furthermore, in November 2017, researchers at the Indian Institute of Technology (IIT) Hyderabad have developed a novel skin patch which releases diclofenac at the target site in a controlled way in such way that, there will be constant release of the drug for as long as 12 hours. In addition, the drug has low half-life of one–two hours and therefor constant release for up to 12 hours offers consistent efficiency of diclofenac for a longer period.

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://bit.ly/2PnEcC4

Market Restraints

Diclofenac patches shows increased risk of heart attack or stroke when applied for longer duration than it prescribed, hindering the growth of diclofenac patches market size. NSAIDs cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction (MI) and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use. Diclofenac patches also associated with major to minor side effects including abnormal pain, constipation, nausea and vomiting, skin rash and tinnitus.

Furthermore, an acceptance of diclofenac patch in the routine practice are low, compared to the diclofenac tablet or injection, which is probably due to the lack of awareness and a mental inertia to accept a new concept among the medical professionals and patients.

Global Diclofenac Patches Market – Regional Analysis

North America holds dominant position in the global diclofenac patches market, owing to the higher prevalence of strains, sprains of muscle and joints in this region, as compared to that in all other regions. According to the National Health Statistics Reports: November 2016, there were an estimated 4,262 numbers of sprains and strains injury are reported in the U.S. between 2011 and 2014, which is also the major cause (41.4%) of natural injury in sports and recreation-related injury episodes.

Global Diclofenac Patches Market – Competitive Landscape

The key players operating in the global diclofenac patches market include Pfizer Inc., Cadila Healthcare, GlaxoSmithKline Pharmaceuticals Ltd., Hisamitsu Pharmaceutical co. Inc., and Teikoku Seiyaku Co. Ltd.

To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/1792

Global Diclofenac Patches Market Taxonomy

By Application

• Lesions
• Sprains
• Strains

By End-User

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/diclofenac-patches-market-1792

Table of Content

Global Diclofenac Patches Market Research Report
Section 1: Global Diclofenac Patches Industry Overview
Section 2: Global Economic Impact on Diclofenac Patches Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Diclofenac Patches Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Diclofenac Patches Market Forecast

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737